+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
AMWILL AMWILL

Amwill Health Care Share Price

₹43.00 +1.39 (3.34%)
48.74% Gain from 52W Low

27 Oct, 2026 4:01 PM (IST)

Amwill Health Care live price: ₹43.00. It opened at ₹43 vs previous close ₹42; intraday high/low: ₹43/₹43. The 50 & 200 DMA stand at ₹43.10/₹44.60.

Amwill Health Care Performance

  • Today's Low
  • ₹43
  • Today's High
  • ₹43
  • 52 Week Low
  • ₹29
  • 52 Week High
  • ₹57
  • Open Price₹43
  • Previous Close₹42
  • Volume1,200
  • 50 DMA₹43.10
  • 100 DMA₹42.20
  • 200 DMA₹44.60

Amwill Health Care Chart

Investment Returns

  • Over 1 Month + 0%
  • Over 3 Month + 3.42%
  • Over 6 Month + 23.21%
  • Over 1 Year -16.23%

Smart Investing Starts Here Start SIP with Amwill Health Care for Steady Growth!

Invest Now

Amwill Health Care Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 7.5
  • PEG Ratio
  • -
  • Market Cap Cr
  • 86
  • P/B Ratio
  • 1.1
  • Average True Range
  • 1.5
  • EPS
  • 5.7
  • Dividend Yield
  • 1.2
  • MACD Signal
  • -
  • RSI
  • 48.18
  • MFI
  • 40.72

Latest Stock News Updates

Amwill Health Care Ltd - 544353 - Approval Of Unaudited Financial Results Of The Company For The Half Year Ended September 30, 2026, For The Financial Year 2026-27.

Approval of unaudited Financial Results of the Compnay for the half year ended September 30, 2026, for the financial year 2026-27.

Amwill Health Care Ltd - 544353 - Board Meeting Outcome for Board Meeting Outcome Of The Meeting Of The Board Of Directors Held On October 23Rd, 2026.

Outcome of the meeting of the Board of Directors held on October 23, 2026: Approval of Unaudited Financial Results of the Company for the half year ended September 30, 2026; Declaration of an Interim Dividend of ?0.50/- per equity share of face value ?10/- each, i.e., @ 5% of the paid-up value per share, for the financial year 2026-27.

Amwill Health Care Ltd - 544353 - Board Meeting Intimation for Approval And Take On Record Unaudited Financial Results Of The Company For The Half Year Ended September 30, 2026 (H1) Of Financial Year 2026-27 And Consider Declaration Of An Interim Dividend To The Equity Shareholders.

Amwill Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2026 ,inter alia, to consider and approve Unaudited Financial Results of the Company for the half year ended September 30, 2026 (H1) of Financial Year 2026-27 and consider declaration of an interim dividend to the equity shareholders.

Amwill Health Care Financials

Amwill Health Care Technicals

EMA & SMA

Current Price
₹43.00
+ 1.39 (3.34%)
pointer
  • Bearish Moving Average 12
  • Bullish Moving Average 4
  • 20 Day
  • ₹43.50
  • 50 Day
  • ₹43.10
  • 100 Day
  • ₹42.20
  • 200 Day
  • ₹44.60

Resistance and Support

43 Pivot Speed
  • R3 43.00
  • R2 43.00
  • R1 43.00
  • S1 43.00
  • S2 43.00
  • S3 43.00

Amwill Health Care Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-23 Half Yearly Results & Interim Dividend
2026-05-30 Audited Results & Final Dividend
2025-11-04 Half Yearly Results (Revised)
2025-05-29 Audited Results
Date Purpose Remarks
2026-10-30 INTERIM Rs.0.50 per share(5%)Interim Dividend
2026-08-08 FINAL Rs.0.50 per share(5%)Final Dividend
View Amwill Health Care Dividend History Arrow

Amwill Health Care Shareholding Pattern

70.65%
28.88%
0.48%

Amwill Health Care FAQs

Amwill Health Care share price is ₹43 As on 27 October, 2026 | 21:58

The Market Cap of Amwill Health Care is ₹86 Cr As on 27 October, 2026 | 21:58

The P/E ratio of Amwill Health Care is 7.5 As on 27 October, 2026 | 21:58

The PB ratio of Amwill Health Care is 1.1 As on 27 October, 2026 | 21:58

The 52 week High & Low of Amwill Health Care is ₹57/₹28.9 respectively As on 27 October, 2026 | 21:58

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23